相似文献
1
Blood-substitute study is criticized by U.S. agency.
Wall St J (East Ed). 2006 Mar 10:A3.
2
Amid alarm bells, a blood substitute keeps pumping; ten in trial have heart attacks, but data aren't published; FDA allows a new study; doctors' pleas are ignored.
Wall St J (East Ed). 2006 Feb 22:A1, A12.
3
FDA to weigh using fake blood in trauma trial.
Wall St J (East Ed). 2006 Jul 6:B1, B2.
4
Artificial-blood study has critics seeing red.
Chron High Educ. 2006 Jun 16;52(41):A17.
5
Use of substitution for blood draws ethics challenge.
Wall St J (East Ed). 2006 Mar 20:A2.
6
FDA to weigh test of blood substitute out of public view.
Wall St J (East Ed). 2006 Jul 11:D3.
7
Rules is rules.
Am J Bioeth. 2006 May-Jun;6(3):40-1; discussion W49-50. doi: 10.1080/15265160600685929.
8
Researchers raise concerns about secrecy in company-sponsored clinical trials.
Chron High Educ. 2006 Apr 7;52(31):A29.
9
Americans should not be on a game show in U.S. emergency rooms and ambulances.
Am J Bioeth. 2010 Oct;10(10):9-10. doi: 10.1080/15265161.2010.525165.
10
Acting out of ethics: what the open letter asks.
Am J Bioeth. 2006 May-Jun;6(3):41-3; discussion W49-50. doi: 10.1080/15265160600685937.
引用本文的文献
1
Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis.
JAMA. 2008 May 21;299(19):2304-12. doi: 10.1001/jama.299.19.jrv80007. Epub 2008 Apr 28.
Zotero 插件